| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Kura Oncology Inc (NASDAQ: KURA)
KURA Technical Analysis
5
| As on 21st Nov 2024 KURA STOCK Price closed @ 10.06 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 13.79 & Strong Sell for SHORT-TERM with Stoploss of 10.82 we also expect STOCK to react on Following IMPORTANT LEVELS. |
KURASTOCK Price
| Open | 11.80 | Change | Price | % |
| High | 12.24 | 1 Day | -5.85 | -36.77 |
| Low | 9.68 | 1 Week | -8.51 | -45.83 |
| Close | 10.06 | 1 Month | -8.10 | -44.60 |
| Volume | 17321855 | 1 Year | -3.64 | -26.57 |
| 52 Week High 23.53 | 52 Week Low 7.58 | ||||
NASDAQ USA Most Active Stocks
| AMRS | 0.14 | 100.00% |
| NVDA | 146.67 | 0.53% |
| AKTS | 0.10 | 11.11% |
| WORX | 2.12 | 116.33% |
| QUBT | 4.76 | 29.35% |
| LMDX | 0.02 | 0.00% |
| SMCI | 29.70 | 5.06% |
| MSTR | 397.28 | -16.16% |
| MARA | 23.81 | 22.17% |
| CRNC | 5.83 | 106.74% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| KURA Daily Charts |
KURA Intraday Charts |
Whats New @ Bazaartrend |
KURA Free Analysis |
|
|
KURA Important Levels Intraday
| RESISTANCE | 14.99 |
| RESISTANCE | 13.41 |
| RESISTANCE | 12.43 |
| RESISTANCE | 11.46 |
| SUPPORT | 8.66 |
| SUPPORT | 7.69 |
| SUPPORT | 6.71 |
| SUPPORT | 5.13 |
KURA Forecast November 2024
| 4th UP Forecast | 14.63 |
| 3rd UP Forecast | 13.16 |
| 2nd UP Forecast | 12.26 |
| 1st UP Forecast | 11.35 |
| 1st DOWN Forecast | 8.77 |
| 2nd DOWN Forecast | 7.86 |
| 3rd DOWN Forecast | 6.96 |
| 4th DOWN Forecast | 5.49 |
KURA Weekly Forecast
| 4th UP Forecast | 14.13 |
| 3rd UP Forecast | 12.82 |
| 2nd UP Forecast | 12.02 |
| 1st UP Forecast | 11.21 |
| 1st DOWN Forecast | 8.91 |
| 2nd DOWN Forecast | 8.10 |
| 3rd DOWN Forecast | 7.30 |
| 4th DOWN Forecast | 5.99 |
KURA Forecast2024
| 4th UP Forecast | 42.36 |
| 3rd UP Forecast | 32 |
| 2nd UP Forecast | 25.6 |
| 1st UP Forecast | 19.19 |
| 1st DOWN Forecast | 0.93 |
| 2nd DOWN Forecast | -5.48 |
| 3rd DOWN Forecast | -11.88 |
| 4th DOWN Forecast | -22.24 |
Kura Oncology Inc ( NASDAQ USA Symbol : KURA )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
KURA Business Profile
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. Its pipeline consists of small molecule product candidates that target cancer. The company's lead product candidates are tipifarnib, an orally bioavailable inhibitor of farnesyl transferase that is in Phase II clinical trials for the treatment of solid tumors and hematologic indications; and KO-539, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A protein-protein interaction for the treatment of genetically defined subsets of acute leukemias, including acute myeloid leukemia and acute lymphoblastic leukemia. Kura Oncology, Inc. has a clinical collaboration with Novartis to evaluate the combination of tipifarnib and alpelisib in patients with head and neck squamous cell carcinoma whose tumors have HRAS overexpression or PIK3CA mutation and/or amplification. The company was founded in 2014 and is headquartered in San Diego, California. Address: 12730 High Bluff Drive, San Diego, CA, United States, 92130
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service